May 14 |
Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
May 13 |
Verrica Pharmaceuticals, Inc. (VRCA) Q1 2024 Earnings Call Transcript
|
May 13 |
Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
|
May 13 |
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
|
May 13 |
Verrica Pharmaceuticals Non-GAAP EPS of -$0.38 beats by $0.06, revenue of $3.83M beats by $1.18M
|
May 13 |
Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 9 |
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
|
May 8 |
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
|
May 6 |
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
|
Apr 25 |
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
|